Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111194304A details an enzymatic method for high-purity bridged ring intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover advanced processes for preparing cyclopenta[d]pyrimidin-4-yl piperazine compounds. Enhance supply chain reliability and reduce manufacturing costs for AKT inhibitors.
Patent CN108239019A enables enzymatic synthesis of chiral piperidine esters. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN108912032A details an efficient seven-step synthesis for chiral pyrrolidine derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112680497A reveals enzymatic splitting for high-purity Corey lactone. Achieve significant cost reduction in API intermediate manufacturing and supply reliability.
Solve supply chain risks for (2S,4R)-2-amino-4-methylnonanoic acid with this 8-step, high-yield synthesis. Achieve >99% optical purity at scale. Contact us for CDMO solutions.